Browsing Tag
GOBLET study
3 posts
Is pelareorep gaining traction? Oncolytics Biotech’s updated GOBLET data draws investor focus to third-line anal cancer
Find out why Oncolytics Biotech’s updated GOBLET cohort 4 data is drawing investor attention to pelareorep’s role in third-line anal cancer.
Breakthrough trial: Oncolytics Biotech’s pelareorep combo doubles response rate in advanced anal cancer
Find out how Oncolytics Biotech’s breakthrough trial doubled response rates in advanced anal cancer and set up a 2026 FDA path.
Oncolytics Biotech advances pancreatic cancer study following regulatory approval
Oncolytics Biotech has achieved a critical milestone in its efforts to transform pancreatic cancer treatment, with Germany’s Paul-Ehrlich-Institute…